Building a Safer Future for Medical Device Sterilization: Michelle Scott on Gulf Sterilization | Building Biotech

Episode notes

This week on Building Biotech, Stephanie Glines sits down with Michelle Scott, founder of Gulf Sterilization, to discuss how her company is transforming one of the most overlooked parts of medical device manufacturing. For decades, much of the medical device industry has relied on ethylene oxide sterilization, a process facing growing regulatory pressure and capacity constraints. Gulf Sterilization is developing an alternative approach using chlorine dioxide, offering manufacturers a safer, more sustainable, and potentially faster path to sterilizing medical devices. Michelle shares how the company identified a critical industry bottleneck, the challenges of bringing a new sterilization technology to market, and how participation in the Hatch Biotech Accelerator helped prepare Gulf Sterilization for growth and investment. She also discusses the company's work toward regulatory milestones, the role of AI in streamlining operations, and what's next as Gulf Sterilization continues to scale.

• Turning Personal Pain Into Innovation: Hannah Keel & Brayden Gibson on Southern Rooted | Building Biotech40 / 100
• AI Accelerating Medical Innovation: Vipul Kashyap on Medhive.ai | Building Biotech
• Building Better Drug Testing with Lab-Grown Human Tissue: Yuan Tian on Vivosphere | Building Biotech
• From Air Force Research to a Medical Breakthrough: David Nelson on Spectratherm | Building Biotech
• Turning Mental Health Awareness Into Action: Marlo Young on Mentalocity | Building Biotech